Login / Signup

Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population.

Carmen GruzeiJufen ZhangRupert R A Bourne
Published in: International ophthalmology (2022)
A substantial proportion (10%) of patients in this clinic population would meet recommended gene therapy inclusion criteria.
Keyphrases
  • gene therapy
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • primary care
  • prognostic factors